2World Health Organization, Stop Tb Dept. Guidelines for the programmatic management of drug--resistant tuberculosis[R]. 2008.
3Aziz M, Wright A, Laszlo A. Epidemiology of anti--tuberculosis drug resistance (the Global Project on Anti--tuberculosis Drug Re- sistance Surveillance): an updated analysis[J]. Lancet, 2006,368 (9553): 2142--2154.
4World Health Organization. Multidrug and extensively drug--resistant TB (M/XDR--TB) : 2010 global report on surveillance and response[R]. 2010.
5Farmer P,Kim J Y. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-- plus" [J]. BMJ,1998,317(7159):671--674,.
6Helen S C, Caterina S, Stobdan K, et al. Emergence of Extensive Drug Resistance during Treatmentfor Multidrug--Resistant Tuber- culosis[J]. The new england journal of medicine, 2008,359 (22) : 2398--3400.
7Shin S, Furin j, Bayona J, et al. Community- based treatment of multidrug--resistant tuherculosis in Lima, Peru 7 years of experi- ence[J]. SocSciMed,2004,59(7):1529--1539.
8Padayatchi N,Friedland G. Decentralised management of drug--re sistant tuberculosis (MDR-- and XDR--TB) in South Africa: an alternative model of care[J]. Int J Tuberc Lung Dis, 2008,12(8): 978- 980.
9Revised National Tuberculosis Control Programme. DOTS Plus Guidelines[R]. 2009.
10World Health Organization, Stop Tb Partnership. The global plan to stop TB 2011--2015: transforming the fight towards elimination of tuberculosis[R]. 2010.
